Table 4.

Summary of risk factors for IgAN recurrence.

Risk factors	Protective factors
Young recipient	HLA-B46 antigen
Young donor	Induction with anti-IL-2-R antibodies
Rapid progression from IgAN diagnosis to ESKD	MMF
Short time on dialysis	Pretransplant tonsillectomy
Low total HLA mismatches
Low HLA-DR mismatches
Male recipient
Related donor
Retransplantation
Hemodialysis
No induction therapy
mTOR inhibitor
ACEI/ARB

IgAN, immunoglobulin A nephropathy; ESRD, end stage renal disease; HLA, human leukocyte antigen; ACEI, angiotensin-converting enzyme inhibitors; ARB, angiotensin receptor blockers; MMF, mycophenolate mofetil.